货号:A215667
同义名:
Vanilacetic acid; HVA
Homovanillic acid是一种多巴胺代谢产物,存在于人体生物体液中,也存在于 Ilex rotunda Thunb 的树皮中。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Homovanillic Acid (HVA) is a metabolite of dopamine, reflecting central dopamine metabolism, primarily situated in the striatum[3]. Moreover, reduced CSF (cerebrospinal fluid) HVA in LBD (Lewy body disorder) is supported by the finding that HVA is also reduced in the brains and CSF of PD (Parkinson disease) patients[4].The metoclopramide induced increase of striatal HVA content was dose-dependent[5]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00106353 | Adenocarcinoma ... 展开 >> Neoplasms 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT03180762 | Healthy | Phase 1 | Terminated(Trial stopped A SAE... 展开 >> has occured. As a measure of precaution, the trial has been stopped.) 收起 << | - | Belgium ... 展开 >> Clinical Pharmacology Unit Merksem, Belgium, 2170 收起 << |
NCT00659984 | Neuroblastoma | Phase 2 | Completed | - | United States, California ... 展开 >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Illinois University of Chicago Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Michigan C.S. Mott Children's Hospital at University of Michigan Medical Center Ann Arbor, Michigan, United States, 48109-0286 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
5.49mL 1.10mL 0.55mL |
27.45mL 5.49mL 2.74mL |
54.89mL 10.98mL 5.49mL |
CAS号 | 306-08-1 |
分子式 | C9H10O4 |
分子量 | 182.17 |
SMILES Code | O=C(O)CC1=CC=C(O)C(OC)=C1 |
MDL No. | MFCD00004350 |
别名 | Vanilacetic acid; HVA; Homovanillic acid, HVA, NSC 16682, Vanilacetic Acid; NSC 16682; Vanillacetic acid |
运输 | 蓝冰 |
InChI Key | QRMZSPFSDQBLIX-UHFFFAOYSA-N |
Pubchem ID | 1738 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, room temperature |
溶解方案 |
DMSO: 105 mg/mL(576.37 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 8 mg/mL(43.91 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|